Tributary Capital Management LLC Sells 4,318 Shares of Balchem Corporation (NASDAQ:BCPC)

Tributary Capital Management LLC reduced its stake in Balchem Corporation (NASDAQ:BCPC - Free Report) by 3.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 131,937 shares of the basic materials company's stock after selling 4,318 shares during the period. Balchem makes up about 1.9% of Tributary Capital Management LLC's holdings, making the stock its 14th largest holding. Tributary Capital Management LLC owned 0.40% of Balchem worth $21,902,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the stock. Quadrant Capital Group LLC increased its position in shares of Balchem by 8.2% during the fourth quarter. Quadrant Capital Group LLC now owns 989 shares of the basic materials company's stock valued at $161,000 after buying an additional 75 shares during the period. Covestor Ltd raised its position in shares of Balchem by 93.8% in the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock worth $26,000 after buying an additional 76 shares in the last quarter. Vident Advisory LLC raised its position in shares of Balchem by 6.0% in the fourth quarter. Vident Advisory LLC now owns 1,421 shares of the basic materials company's stock worth $232,000 after buying an additional 80 shares in the last quarter. Heritage Family Offices LLP raised its position in shares of Balchem by 5.9% in the first quarter. Heritage Family Offices LLP now owns 1,504 shares of the basic materials company's stock worth $250,000 after buying an additional 84 shares in the last quarter. Finally, Mackenzie Financial Corp raised its position in shares of Balchem by 2.2% in the fourth quarter. Mackenzie Financial Corp now owns 3,840 shares of the basic materials company's stock worth $626,000 after buying an additional 84 shares in the last quarter. 87.91% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the company. Wall Street Zen downgraded Balchem from a "buy" rating to a "hold" rating in a research report on Wednesday, May 21st. HC Wainwright set a $180.00 price objective on Balchem and gave the stock a "buy" rating in a research report on Monday, April 28th.

Balchem Price Performance

Shares of BCPC stock traded down $5.53 on Friday, reaching $152.84. The company's stock had a trading volume of 232,035 shares, compared to its average volume of 143,548. The company has a market capitalization of $4.99 billion, a P/E ratio of 36.65, a PEG ratio of 3.41 and a beta of 0.89. The company has a quick ratio of 1.40, a current ratio of 2.44 and a debt-to-equity ratio of 0.18. Balchem Corporation has a 12-month low of $145.70 and a 12-month high of $186.03. The stock's 50 day simple moving average is $163.37 and its 200-day simple moving average is $162.72.

Balchem (NASDAQ:BCPC - Get Free Report) last released its earnings results on Thursday, April 24th. The basic materials company reported $1.22 EPS for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). The firm had revenue of $250.52 million during the quarter, compared to the consensus estimate of $245.70 million. Balchem had a net margin of 14.16% and a return on equity of 12.01%. The firm's revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.03 EPS. As a group, equities analysts predict that Balchem Corporation will post 4.64 earnings per share for the current fiscal year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.